Isoxazole ring as a useful scaffold in a search for new therapeutic agents

Eur J Med Chem. 2017 Sep 8:137:292-309. doi: 10.1016/j.ejmech.2017.06.002. Epub 2017 Jun 2.

Abstract

Due to its relatively easy synthesis, isoxazole ring has been as an object of interest for chemists and pharmacologists from research groups all over the world. Its chemical modifications include both connection of isoxazole with other aromatic, heteroaromatic or non aromatic rings and substitution with different alkyl groups. Thanks to their usually low cytotoxicity, isoxazole derivatives are still popular scaffolds for the development of new agents with variable biological activities, such as antimicrobial, antiviral, anticancer, anti-inflammatory, immunomodulatory, anticonvulsant or anti-diabetic properties. This review discusses the chemical structure of recently developed isoxazole derivatives with regards to their activity and potential therapeutic use.

Keywords: Chemical synthesis; Isoxazole; Substituted isoxazoles; Therapeutic agents.

Publication types

  • Review

MeSH terms

  • Analgesics / chemistry
  • Analgesics / therapeutic use
  • Animals
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Anticonvulsants / chemistry
  • Anticonvulsants / therapeutic use
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / therapeutic use
  • Antiviral Agents / chemistry
  • Antiviral Agents / therapeutic use
  • Humans
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / therapeutic use
  • Isoxazoles / chemistry
  • Isoxazoles / therapeutic use*
  • Platelet Aggregation Inhibitors / chemistry
  • Platelet Aggregation Inhibitors / therapeutic use

Substances

  • Analgesics
  • Anti-Infective Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticonvulsants
  • Antineoplastic Agents
  • Antiviral Agents
  • Hypoglycemic Agents
  • Isoxazoles
  • Platelet Aggregation Inhibitors